Evox Therapeutics completes £69 2 million Series C financing prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PQShield publishes white paper series to educate business leaders on the quantum threat to information security
PQShield, the cybersecurity company specialising in post-quantum cryptography, has today published a
series of white papers explaining the quantum threat to information security and outlining the solutions that will help organisations to protect their sensitive information for the future.
When full-scale quantum computers arrive, they will be able to break the public-key encryption widely relied on to protect sensitive data, accessing all digital information - past, present and future. Knowing the sheer scale of the quantum security threat, engineers and scientists around the world have been working to develop a new generation of encryption - post-quantum cryptography - that will enable organisations to protect their sensitive data now and for years to come.
PQShield publishes white paper series to educate business leaders on the quantum threat to information security prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support .
SpyBiotechFebruary 10, 2021 GMT
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology
Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated
Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource
ADVERTISEMENT
OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairma